ARTICLE | Company News
Baxter, GenOdyssee deal
October 30, 2006 8:00 AM UTC
GenOdyssee will use its natural genetic variation technologies to discover blood-clotting factors for BAX's Baxter AG subsidiary. BAX will have rights to resulting products. Further terms were not dis...